MoneyWorks4Me

Suven Life Sciences - Quaterly Results

29 Oct 2024 Evaluate
The sales declined to Rs. 25.73 millions for the September 2024 quarter as compared to Rs. 30.60 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2024 is Rs. -110.72 millions as compared to Net Profit of Rs. 27.55 millions of corresponding quarter ended September 2023 Operating profit Margin for the quarter ended September 2024 improved to -96.01% as compared to -29.34% of corresponding quarter ended September 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 25.73 30.60 -15.92 35.79 68.57 -47.81 116.93 135.39 -13.63
Other Income 40.35 51.42 -21.53 79.66 107.82 -26.12 211.30 84.49 150.09
PBIDT -96.01 -29.34 227.23 -157.58 -40.89 285.38 -98.07 -192.95 -49.17
Interest 0.16 0.42 -61.90 0.39 0.93 -58.06 1.58 2.89 -45.33
PBDT -96.17 44.81 -314.62 -157.97 32.75 -582.35 -25.08 -135.84 -81.54
Depreciation 14.55 17.26 -15.70 29.41 33.90 -13.24 65.02 65.43 -0.63
PBT -110.72 27.55 -501.89 -187.38 -1.15 16193.91 -90.10 -201.27 -55.23
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -10.02 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -110.72 27.55 -501.89 -187.38 -1.15 16193.91 -80.08 -201.27 -60.21
Equity 218.07 218.07 0.00 218.07 218.07 0.00 218.07 218.07 0.00
PBIDTM(%) -373.14 -95.88 289.17 -440.29 -59.63 638.34 -83.87 -142.51 -41.15
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..